2
Boatman Biotech, Shanghai, China) according to the manufacturer's instructions.
Mouse model of experimental DN
In the current study, we used a long-term model of STZ-induced DN to test therapeutic intervention. Briefly, persistent hyperglycemia was induced in 8-week-old male C57BL/6 mice with a mean body weight of 20g by a daily intraperitoneal injection of STZ (50mg/kg body weight, freshly dissolved in 100 mM sterile sodium citrate buffer, pH 4.5) for 5 consecutive days. Age-matched mice intraperitoneally injected with sodium citrate buffer alone for 5 consecutive days served as controls. Nonfasting blood glucose was monitored weekly for the first 2 weeks after the last STZ injection to determine the development of hyperglycemia. Mice were sacrificed and examined for the establishment of DN by histopathological analysis of PAS-stained renal sections at 16 weeks after the last STZ injection.
Construction of therapeutic plasmid DNA encoding murine IL-22
Nucleotide sequence encoding murine IL-22, synthesized by GeneScript Biotech (Nanjing, China), was sub-cloned into the Kpn I and BamH I sites in the pVAX1 therapeutic plasmid vector (Invitrogen, Carlsbad, CA, USA). The resulting plasmids pVAX1mIL22 were transformed into E.coli competent cells Top10 (TIANGEN Biotech, Beijing, China) and verified by sequencing analysis. Subsequently, the recombinant pVAX1mIL22 plasmids and empty vector pVAX1 plasmids were prepared in large amounts using the EndoFree Plasmid Maxiprep Kit (Biotool, Houston, TX, USA). The concentration and purity of endotoxin-free plasmids were measured by Nanodrop 2000 Spectrophotometer (Thermo Scientific, Waltham, MA, USA).
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Expression of IL-22 in vitro
Human embryonic kidney cells HEK293T, maintained in DMEM medium supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/mL) and streptomycin (100 µg/mL), were obtained from Cell Bank of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Shanghai, China). The endotoxinfree pVAX1mIL22 or pVAX1 plasmids were transfected into HEK293T cells using 
Expression of IL-22 in vivo
To determine the in vivo expression of murine IL-22, 8-week-old male C57BL/6 mice were randomly divided into three groups (five mice in each group): (1) naive control group (2) pVAX1 empty vector control group (3) pVAX1mIL22 therapeutic intervention group. 100 µg of the recombinant plasmid pVAX1mIL22 or empty vector pVAX1 were administered to mice by bilateral intramuscular injection under sodium pentobarbital anesthesia. Serum levels of IL-22 at indicated time points were determined by ELISA according to the manufacturer's instructions.
Biochemical parameters analysis
Serum creatinine, blood urea nitrogen (BUN) and proteinuria were determined to evaluate kidney function. Serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured to assess liver injury. The related detection kits 4 for biochemical parameters analysis were all purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China) and used according to the manufacturer's instructions.
Caspase-1 activity assay
The enzymatic activity of Caspase-1 in renal tissue was determined by Caspase-1 Activity Detection Kit (Beyotime Institute of Biotechnology, Beijing, China) according to the manufacturer's protocol on the basis of ability of Caspase-1 to change acetyl-TyrVal-Ala-Asp p-nitroanilide (Ac-YVAD-pNA) into the yellow formazan product pnitroaniline (pNA).
Glomerular mesangial cell and renal tubular epithelial cell culture and treatment
Mouse glomerular mesangial cells SV40MES13 and human renal tubular epithelial cells HK-2 were obtained from Cell Bank of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Shanghai, China) and maintained in RPMI1640 medium supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/mL) and streptomycin (100 µg/mL) in a 95% air and 5% CO2 atmosphere at 37 ℃. 
